SCHNEIDER PHILLIP M
Insider CIK 1230051 · ARNA Director · ASPX Director · PFNX Director · SPRY Director · LBPH Director · GPRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 12,500 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 25,461 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 12,367 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 22,500 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-05-23 | 2024-05-24 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-06-27 | 2023-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2023-05-25 | 2023-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 76,823 | — | $0 | 76,823 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 153,647 | — | $0 | 153,647 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2022-05-24 | 2022-05-31 | 12,367 | — | $0 | 12,367 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 18,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 18,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 20,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 18,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 18,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender deriv | 2020-10-01 | 2020-10-05 | 18,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | U Tender | 2020-10-01 | 2020-10-05 | 11,000 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2020-05-08 | 2020-05-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PFNX Pfenex Inc. | P Buy | 2018-09-11 | 2018-09-13 | 11,000 | $4.99 | $54.9K | 11,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2018-05-09 | 2018-05-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-14 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2017-05-05 | 2017-05-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2016-06-13 | 2016-06-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2016-05-06 | 2016-05-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2015-06-12 | 2015-06-16 | 40,145 | — | $0 | 94,257 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 13,333 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 6,667 | — | $0 | 0 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2015-04-21 | 2015-04-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2014-07-24 | 2014-07-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2014-06-13 | 2014-06-16 | 25,384 | — | $0 | 54,112 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | A Award deriv | 2014-05-06 | 2014-05-07 | 6,667 | — | $0 | 6,667 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2013-06-10 | 2013-06-11 | 18,728 | — | $0 | 28,728 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | $37.10 | $278.3K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | — | $0 | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | $39.51 | $296.3K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 7,500 | $25.00 | $187.5K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 10,000 | $28.66 | $286.6K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 10,000 | $39.20 | $392.0K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer deriv | 2012-08-01 | 2012-08-02 | 10,000 | $40.81 | $408.1K | 0 | SEC↗ |
| GPRO GEN PROBE INC | D To issuer | 2012-08-01 | 2012-08-02 | 10,995 | $82.75 | $909.8K | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2012-06-15 | 2012-06-18 | 48,000 | — | $0 | 48,000 | SEC↗ |
| GPRO GEN PROBE INC | A Award | 2012-04-02 | 2012-04-04 | 68 | $67.26 | $4.6K | 10,995 | SEC↗ |
| GPRO GEN PROBE INC | M Exercise deriv | 2012-02-14 | 2012-02-15 | 10,000 | — | $0 | 0 | SEC↗ |
| GPRO GEN PROBE INC | M Exercise deriv | 2012-02-14 | 2012-02-15 | 10,000 | — | $0 | 0 | SEC↗ |
| GPRO GEN PROBE INC | M Exercise | 2012-02-14 | 2012-02-15 | 10,000 | $19.19 | $191.9K | 30,927 | SEC↗ |
| GPRO GEN PROBE INC | S Sale | 2012-02-14 | 2012-02-15 | 20,000 | $70.00 | $1.40M | 10,927 | SEC↗ |
| GPRO GEN PROBE INC | M Exercise | 2012-02-14 | 2012-02-15 | 10,000 | $52.69 | $526.9K | 20,927 | SEC↗ |
| GPRO GEN PROBE INC | A Award | 2012-01-03 | 2012-01-05 | 78 | $58.93 | $4.6K | 10,927 | SEC↗ |